title: The editor's roundtable: medical management of atrial fibrillation.
authors.affiliation: Department of Internal Medicine, The University of Texas Medical School at Houston, USA. vfriedew@nd.edu
authors.forename: Vincent E
authors.initials: VE
authors.lastname: Friedewald
authors.forename: Robert C
authors.initials: RC
authors.lastname: Kowal
authors.forename: Brian
authors.initials: B
authors.lastname: Olshansky
authors.forename: Clyde W
authors.initials: CW
authors.lastname: Yancy
authors.forename: William C
authors.initials: WC
authors.lastname: Roberts
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000503:physiopathology; D015415:Biomarkers / Q000097:blood; D017115:Catheter Ablation; D003920:Diabetes Mellitus / Q000503:physiopathology; D003971:Diastole / Q000502:physiology; D004108:Dilatation, Pathologic / Q000503:physiopathology; D006325:Heart Atria / Q000503:physiopathology; D006333:Heart Failure / Q000503:physiopathology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D055118:Medication Adherence; D011183:Postoperative Complications; D018570:Risk Assessment; D020521:Stroke / Q000209:etiology / Q000517:prevention & control; D013318:Stroke Volume / Q000502:physiology; D013599:Systole / Q000502:physiology
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D015415:Biomarkers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors